[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
IJRR Information::
For Authors::
For Reviewers::
Subscription::
News & Events::
Web Mail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
ISSN
Hard Copy 2322-3243
Online 2345-4229
..
Online Submission
Now you can send your articles to IJRR office using the article submission system.
..

AWT IMAGE

AWT IMAGE

:: ::
Back to the articles list Back to browse issues page
Role of microRNA-665 in modulating PI3K/AKT/JNK signaling pathways: implications for radiation-induced neurobehavioral disorders
J. Yang , R. Luan , X. Zhao
Department of Psychiatry, The Affiliated Xi’an Central Hospital of Xi’an Jiaotong University, Xi’an, 710003, Shaanxi Province, China , 18791083860@163.com
Abstract:   (12 Views)
Background: Radiotherapy is an essential treatment for brain tumors but often causes radiation-induced brain injury (RIBI), leading to neurobehavioral deficits such as depression-like behaviors. MicroRNA-665 (miR-665) may regulate these injury pathways through its interaction with the PI3K/AKT (pro-survival) and JNK/p38 (pro-apoptotic) signaling cascades. Materials and Methods: Ninety-six male C57BL/6 mice received 10 Gy cranial irradiation and were assigned to four groups (n=24): control, radiation + pioglitazone (PIO), radiation + PIO + GW9662, and radiation + PIO + LY294002 or anisomycin. Depression-like behaviors were assessed by sucrose preference, open field, and forced swimming tests. miR-665 expression and signaling markers (p-AKT, p-JNK, p-p38) in the PFC were measured using qPCR and Western blot. Results: Cranial irradiation significantly reduced sucrose preference, exploratory activity, and increased immobility time (all P < 0.01). PIO pretreatment activated PI3K/AKT and suppressed JNK/p38 signaling, producing marked behavioral improvement (P < 0.01). These neuroprotective effects were fully abolished by GW9662 (PPAR-γ antagonist), LY294002 (PI3K inhibitor), and anisomycin (JNK/p38 activator). miR-665 expression increased 2.8-fold in the GW9662 group (P < 0.01), where PPAR-γ and PI3K/AKT protection were blocked, but was reduced (0.4–0.5-fold) when PI3K/AKT was inhibited or JNK/p38 was activated. Conclusion: These findings indicate that PIO protects against radiation-induced depression-like behaviors via PPAR-γ–dependent activation of PI3K/AKT and inhibition of JNK/p38. The bidirectional changes in miR-665 strongly suggest it acts as a negative regulator of the PI3K/AKT pathway or is suppressed by JNK/p38 activation. miR-665 may therefore represent a promising therapeutic target for mitigating neurobehavioral complications of cranial radiotherapy.
Keywords: miR-665, Cranial irradiation, Depression-like behavior, PI3K/AKT pathway, JNK/p38 pathway.
Full-Text [PDF 1038 kb]   (3 Downloads)    
Type of Study: Original Research | Subject: Radiation Biology
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Back to the articles list Back to browse issues page
International Journal of Radiation Research
Persian site map - English site map - Created in 0.15 seconds with 50 queries by YEKTAWEB 4741